ERBB4 and breast carcinoma: Adding a monoclonal antibody of ErbB4 to non-small-cell lung cancer cells expressing ErbB4 can inhibit cell growth and promote cell apoptosis [21], deletion of ErbB4 can result in proliferation of human breast cancer cells [22], and these all indicate that ErbB4 has a tumor suppressive effect.